News

Both the companies have agreed to move forward independently. As of 12 March 2012, all rights licensed to Pfizer will revert to Biocon, and all insulin distributed under

Pulmaquin is a once-a-day novel inhaled formulation consisting of a proprietary mixture of unencapsulated ciprofloxacin and ciprofloxacin encapsulated in liposomes. The formulation allows for both immediate and sustained

As per the Indian Patents Act, Natco Pharma will be able to make and sell low-cost drug in the country, through a pact with the patent holder, at

The company’s submission provides information to the FDA on Prurisol supporting a pre-IND meeting. With the meeting, Cellceutix intends for guidance to attain approval for a section 505(b)(2)

The project will focus on the development of a proprietary monitoring and control methodology, enabling robust growth of adherent human pluripotent stem cells in EMD Millipore’s Mobius CellReady

Immunovaccine said the new vaccine would prevent cocaine molecules from reaching the brain by stimulating the body’s own immune system. As part of the project, Cornell’s novel cocaine

Talactoferrin is currently manufactured by DSM for use in ongoing clinical trials, including the FORTIS-M trial in non-small cell lung cancer (NSCLC). DSM Pharmaceutical Products business unit DSM

ImmunoCellular said ICT-107 is its lead dendritic cell (DC) based vaccine for the treatment of glioblastoma multiforme (GBM). The company in collaboration with its partners has developed the

Ranbaxy Morocco has been authorized by the Moroccan Health Authorities to commence manufacturing of its products at its Casablanca facility. With this new facility, Ranbaxy is expected to